GALECTIN THERAPEUTICS INC. Operating Cash Flow
GALECTIN THERAPEUTICS INC. (GALT) reported Operating Cash Flow of -$6.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.44M.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.87M.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.04M.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.54M.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2025 was -$23.88M.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2024 was -$41.77M.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2023 was -$32.97M.
- GALECTIN THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2022 was -$31.06M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 132 month | Net Cash Provided by (Used in) Operating Activities 135 month | Net Cash Provided by (Used in) Operating Activities 138 month | Net Cash Provided by (Used in) Operating Activities 141 month | Net Cash Provided by (Used in) Operating Activities 144 month | Net Cash Provided by (Used in) Operating Activities 147 month | Net Cash Provided by (Used in) Operating Activities 150 month | Net Cash Provided by (Used in) Operating Activities 153 month | Net Cash Provided by (Used in) Operating Activities 156 month | Net Cash Provided by (Used in) Operating Activities 159 month | Net Cash Provided by (Used in) Operating Activities 162 month | Net Cash Provided by (Used in) Operating Activities 165 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$6.30M 10-Q · filed 2026-08-14 | -$12.35M derived: sum of 3 quarters · filed 2026-08-14 | -$15.89M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2026-03-31 | -$3.87M 10-Q · filed 2026-05-15 | -$9.91M derived: sum of 2 quarters · filed 2026-05-15 | -$13.45M derived: sum of 3 quarters · filed 2026-05-15 | -$20.05M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-12-31 | -$6.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$9.58M derived: sum of 2 quarters · filed 2026-03-31 | -$16.19M derived: sum of 3 quarters · filed 2026-08-14 | -$23.88M 10-K · filed 2026-03-31 | ||||||||||||
| 2025-09-30 | -$3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$10.14M derived: sum of 2 quarters · filed 2026-08-14 | -$17.83M 10-Q · filed 2025-11-14 | -$30.62M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-06-30 | -$6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$14.29M 10-Q · filed 2026-08-14 | -$27.08M derived: sum of 3 quarters · filed 2026-08-14 | -$35.62M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-03-31 | -$7.69M 10-Q · filed 2026-05-15 | -$20.48M derived: sum of 2 quarters · filed 2026-05-15 | -$29.02M derived: sum of 3 quarters · filed 2026-05-15 | -$37.35M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||
| 2024-12-31 | -$12.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$21.33M derived: sum of 2 quarters · filed 2026-03-31 | -$29.66M derived: sum of 3 quarters · filed 2026-03-31 | -$41.77M 10-K · filed 2026-03-31 | ||||||||||||
| 2024-09-30 | -$8.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$16.87M derived: sum of 2 quarters · filed 2025-11-14 | -$28.98M 10-Q · filed 2025-11-14 | -$33.68M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||||
| 2024-06-30 | -$8.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$20.44M 10-Q · filed 2025-08-14 | -$25.14M derived: sum of 3 quarters · filed 2025-08-14 | -$32.78M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||
| 2024-03-31 | -$12.11M 10-Q · filed 2025-05-15 | -$16.81M derived: sum of 2 quarters · filed 2025-05-15 | -$24.44M derived: sum of 3 quarters · filed 2025-05-15 | -$34.28M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||
| 2023-12-31 | -$4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$12.34M derived: sum of 2 quarters · filed 2025-03-31 | -$22.17M derived: sum of 3 quarters · filed 2025-03-31 | -$32.97M 10-K · filed 2025-03-31 | ||||||||||||
| 2023-09-30 | -$7.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$17.47M derived: sum of 2 quarters · filed 2024-11-14 | -$28.26M 10-Q · filed 2024-11-14 | -$35.50M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||
| 2023-06-30 | -$9.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$20.63M 10-Q · filed 2024-08-13 | -$27.86M derived: sum of 3 quarters · filed 2024-08-13 | -$36.21M derived: sum of 4 quarters · filed 2024-08-13 | ||||||||||||
| 2023-03-31 | -$10.79M 10-Q · filed 2024-05-15 | -$18.03M derived: sum of 2 quarters · filed 2024-05-15 | -$26.38M derived: sum of 3 quarters · filed 2024-05-15 | -$33.81M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||
| 2022-12-31 | -$7.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$15.59M derived: sum of 2 quarters · filed 2024-03-29 | -$23.01M derived: sum of 3 quarters · filed 2024-03-29 | -$31.06M 10-K · filed 2024-03-29 | ||||||||||||
| 2022-09-30 | -$8.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$15.78M derived: sum of 2 quarters · filed 2023-11-13 | -$23.82M 10-Q · filed 2023-11-13 | -$30.77M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2022-06-30 | -$7.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$15.47M 10-Q · filed 2023-08-14 | -$22.42M derived: sum of 3 quarters · filed 2023-08-14 | -$27.42M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||||
| 2022-03-31 | -$8.04M 10-Q · filed 2023-05-15 | -$14.99M derived: sum of 2 quarters · filed 2023-05-15 | -$19.99M derived: sum of 3 quarters · filed 2023-05-15 | -$25.97M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||||
| 2021-12-31 | -$6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$11.95M derived: sum of 2 quarters · filed 2023-03-30 | -$17.93M derived: sum of 3 quarters · filed 2023-03-30 | -$24.31M 10-K · filed 2023-03-30 | ||||||||||||
| 2021-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$10.97M derived: sum of 2 quarters · filed 2022-11-14 | -$17.36M 10-Q · filed 2022-11-14 | -$22.77M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||
| 2021-06-30 | -$5.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$12.36M 10-Q · filed 2022-08-15 | -$17.77M derived: sum of 3 quarters · filed 2022-08-15 | -$25.98M derived: sum of 4 quarters · filed 2022-08-15 | ||||||||||||
| 2021-03-31 | -$6.38M 10-Q · filed 2022-05-16 | -$11.80M derived: sum of 2 quarters · filed 2022-05-16 | -$20.01M derived: sum of 3 quarters · filed 2022-05-16 | -$22.61M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||
| 2020-12-31 | -$5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$13.63M derived: sum of 2 quarters · filed 2022-03-31 | -$16.23M derived: sum of 3 quarters · filed 2022-03-31 | -$20.60M 10-K · filed 2022-03-31 | ||||||||||||
| 2020-09-30 | -$8.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$10.82M derived: sum of 2 quarters · filed 2021-11-15 | -$15.19M 10-Q · filed 2021-11-15 | -$18.95M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||
| 2020-06-30 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$6.97M 10-Q · filed 2021-08-16 | -$10.73M derived: sum of 3 quarters · filed 2021-08-16 | -$12.21M derived: sum of 4 quarters · filed 2021-08-16 | ||||||||||||
| 2020-03-31 | -$4.37M 10-Q · filed 2021-05-17 | -$8.13M derived: sum of 2 quarters · filed 2021-05-17 | -$9.61M derived: sum of 3 quarters · filed 2021-05-17 | -$11.94M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||||||
| 2019-12-31 | -$3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$5.23M derived: sum of 2 quarters · filed 2021-03-31 | -$7.56M derived: sum of 3 quarters · filed 2021-03-31 | -$10.85M 10-K · filed 2021-03-31 | ||||||||||||
| 2019-09-30 | -$1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$3.81M derived: sum of 2 quarters · filed 2020-11-09 | -$7.09M 10-Q · filed 2020-11-09 | -$9.10M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||
| 2019-06-30 | -$2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$5.61M 10-Q · filed 2020-08-10 | -$7.62M derived: sum of 3 quarters · filed 2020-08-10 | -$9.20M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||
| 2019-03-31 | -$3.28M 10-Q · filed 2020-05-11 | -$5.29M derived: sum of 2 quarters · filed 2020-05-11 | -$6.87M derived: sum of 3 quarters · filed 2020-05-11 | -$9.95M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||
| 2018-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$3.58M derived: sum of 2 quarters · filed 2020-03-16 | -$6.66M derived: sum of 3 quarters · filed 2020-03-16 | -$10.18M 10-K · filed 2020-03-16 | ||||||||||||
| 2018-09-30 | -$1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$4.66M derived: sum of 2 quarters · filed 2019-11-12 | -$8.17M 10-Q · filed 2019-11-12 | -$12.08M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||
| 2018-06-30 | -$3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$6.59M 10-Q · filed 2019-08-09 | -$10.50M derived: sum of 3 quarters · filed 2019-08-09 | -$13.62M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||||
| 2018-03-31 | -$3.52M 10-Q · filed 2019-05-10 | -$7.42M derived: sum of 2 quarters · filed 2019-05-10 | -$10.54M derived: sum of 3 quarters · filed 2019-05-10 | |||||||||||||
| 2017-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$7.03M derived: sum of 2 quarters · filed 2019-03-06 | -$15.89M 10-K · filed 2019-03-06 | |||||||||||||
| 2017-09-30 | -$3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$11.99M 10-Q · filed 2018-11-13 | ||||||||||||||
| 2017-06-30 | -$8.87M 10-Q · filed 2018-08-14 | |||||||||||||||
| 2014-03-31 | -$3.62M 10-Q · filed 2014-05-13 | -$5.26M derived: sum of 2 quarters · filed 2014-05-13 | -$6.75M derived: sum of 3 quarters · filed 2014-05-13 | -$8.68M derived: sum of 4 quarters · filed 2014-05-13 | -$69.66M 10-Q · filed 2014-05-13 | |||||||||||
| 2013-12-31 | -$1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | -$3.13M derived: sum of 2 quarters · filed 2014-03-21 | -$5.06M derived: sum of 3 quarters · filed 2014-03-21 | -$7.48M 10-K · filed 2014-03-21 | -$66.04M 10-K · filed 2014-03-21 | |||||||||||
| 2013-09-30 | -$1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$3.42M derived: sum of 2 quarters · filed 2013-11-12 | -$5.84M 10-Q · filed 2013-11-12 | -$7.59M derived: sum of 4 quarters · filed 2014-05-13 | -$64.39M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$4.36M 10-Q · filed 2013-08-14 | -$6.11M derived: sum of 3 quarters · filed 2014-05-13 | -$8.19M derived: sum of 4 quarters · filed 2014-05-13 | -$62.91M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | -$2.42M 10-Q · filed 2014-05-13 | -$4.17M derived: sum of 2 quarters · filed 2014-05-13 | -$6.25M derived: sum of 3 quarters · filed 2014-05-13 | -$8.44M derived: sum of 4 quarters · filed 2014-05-13 | -$60.98M 10-Q · filed 2013-05-10 | |||||||||||
| 2012-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | -$3.83M derived: sum of 2 quarters · filed 2014-03-21 | -$6.01M derived: sum of 3 quarters · filed 2014-03-21 | -$7.50M 10-K · filed 2014-03-21 | -$58.55M 10-K · filed 2013-03-29 | |||||||||||
| 2012-09-30 | -$2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$4.26M derived: sum of 2 quarters · filed 2013-11-12 | -$5.75M 10-Q · filed 2013-11-12 | -$7.29M derived: sum of 4 quarters · filed 2013-11-12 | -$56.80M 10-Q · filed 2012-11-09 | |||||||||||
| 2012-06-30 | -$2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$3.67M 10-Q · filed 2013-08-14 | -$5.21M derived: sum of 3 quarters · filed 2013-08-14 | -$6.46M derived: sum of 4 quarters · filed 2013-08-14 | -$54.72M 10-Q · filed 2012-08-10 | |||||||||||
| 2012-03-31 | -$1.49M 10-Q · filed 2013-05-10 | -$3.03M derived: sum of 2 quarters · filed 2013-05-10 | -$4.28M derived: sum of 3 quarters · filed 2013-05-10 | -$5.79M derived: sum of 4 quarters · filed 2013-05-10 | -$52.54M 10-Q · filed 2012-05-11 | |||||||||||
| 2011-12-31 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$2.79M derived: sum of 2 quarters · filed 2013-03-29 | -$4.31M derived: sum of 3 quarters · filed 2013-03-29 | -$5.68M 10-K · filed 2013-03-29 | -$51.05M 10-K · filed 2012-03-30 | |||||||||||
| 2011-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$2.77M derived: sum of 2 quarters · filed 2012-11-09 | -$4.13M 10-Q · filed 2012-11-09 | -$4.72M derived: sum of 4 quarters · filed 2012-11-09 | -$49.51M 10-Q · filed 2011-11-10 | |||||||||||
| 2011-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | -$2.88M 10-Q · filed 2012-08-10 | -$3.47M derived: sum of 3 quarters · filed 2012-08-10 | -$4.29M derived: sum of 4 quarters · filed 2012-08-10 | -$48.26M 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | -$1.37M 10-Q · filed 2012-05-11 | -$1.95M derived: sum of 2 quarters · filed 2012-05-11 | -$2.78M derived: sum of 3 quarters · filed 2012-05-11 | |||||||||||||
| 2010-12-31 | -$583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$1.41M derived: sum of 2 quarters · filed 2012-03-30 | -$3.10M 10-K · filed 2012-03-30 | |||||||||||||
| 2010-09-30 | -$827.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$2.52M 10-Q · filed 2011-11-10 | ||||||||||||||
| 2010-06-30 | -$1.69M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |